Logo - International Journal of Pharmaceutical Compounding

Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse)

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2020 - Volume 24, Number 5
View All Articles in Issue

Note:  Electronic version includes supplemental material.

Abstract:  A formulation for preparing Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, ketamine, acepromazine, phenothiazine-derivative psychotropic drug, xylazine, formulations, rat, hamster, mouse, laboratory animals, anesthetic, anesthesia, analgesia, analgesic, pain relief, sedative, antiemetic agent, emesis, vomiting, muscle relaxant, aseptic processing, compounded sterile preparation

Related Categories: FORMULATIONS, PAIN MANAGEMENT, STERILE PREPARATIONS, VETERINARY, SURGERY

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4846

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products